JP2009509532A - コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 - Google Patents
コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 Download PDFInfo
- Publication number
- JP2009509532A JP2009509532A JP2008533536A JP2008533536A JP2009509532A JP 2009509532 A JP2009509532 A JP 2009509532A JP 2008533536 A JP2008533536 A JP 2008533536A JP 2008533536 A JP2008533536 A JP 2008533536A JP 2009509532 A JP2009509532 A JP 2009509532A
- Authority
- JP
- Japan
- Prior art keywords
- seq
- enzyme
- chondroitinase
- chondroitinase abci
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
- C12Y402/02004—Chondroitin ABC lyase (4.2.2.4), i.e. chondroitinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
【選択図】 図1
Description
本願は、「コンドロイチナーゼABCI変異体を用いた組成物およびその使用方法」を表題とする2005年9月26日付出願の米国出願第60/720,628号に対して優先権を主張するものであり、その内容はこの参照により本願明細書に完全に組み込まれるものである。
Claims (22)
- BC6(配列ID番号1)、BE7(配列ID番号2)、BF4(配列ID番号3)から選択される、変異コンドロイチナーゼABCI酵素。
- 請求項1記載の変異コンドロイチナーゼABCI酵素において、前記酵素はBC6(配列ID番号1)を有するものである。
- 請求項1記載の変異コンドロイチナーゼABCI酵素において、前記酵素はBE7(配列ID番号2)を有するものである。
- 請求項1記載の変異コンドロイチナーゼABCI酵素において、前記酵素はBF4(配列ID番号3)を有するものである。
- 中枢神経系を治療する方法であって、BC6(配列ID番号1)、BE7(配列ID番号2)、およびBF4(配列ID番号3)から選択される変異コンドロイチナーゼABCI酵素の治療的有効量を投与する工程を有する、方法。
- 請求項5記載の方法において、前記変異コンドロイチナーゼABCI酵素は前記中枢神経系の挫傷後に投与されるものである。
- 請求項5記載の方法において、前記変異コンドロイチナーゼABCI酵素は前記中枢神経系の非挫傷性損傷後に投与されるものである。
- 請求項5記載の方法において、前記変異コンドロイチナーゼABCI酵素は脊髄損傷後に投与されるものである。
- 請求項5記載の方法において、前記変異コンドロイチナーゼABCI酵素は局所投与されるものである。
- 請求項9記載の方法において、前記局所投与は髄腔内投与および表面投与から選択されるものである。
- 請求項5記載の方法において、前記酵素はBC6(配列ID番号1)を有するものである。
- 請求項5記載の方法において、前記酵素はBE7(配列ID番号2)を有するものである。
- 請求項5記載の方法において、前記酵素はBF4(配列ID番号3)を有するものである。
- 神経の成長を促す方法であって、BC6(配列ID番号1)、BE7(配列ID番号2)、およびBF4(配列ID番号3)から選択される変異コンドロイチナーゼABCI酵素の治療的有効量を投与する工程を有する、方法。
- 請求項14記載の方法において、前記変異コンドロイチナーゼABCI酵素は、前記中枢神経系の挫傷後に投与されるものである。
- 請求項14記載の方法において、前記変異コンドロイチナーゼABCI酵素は、前記中枢神経系の非挫傷性損傷後に投与されるものである。
- 請求項14記載の方法において、前記変異コンドロイチナーゼABCI酵素は脊髄損傷後に投与されるものである。
- 請求項14記載の方法において、前記変異コンドロイチナーゼABCI酵素は局所投与されるものである。
- 請求項18記載の方法において、前記局所投与は、髄腔内投与および表面投与から選択されるものである。
- 請求項14記載の方法において、前記酵素は、BC6(配列ID番号1)を有するものである。
- 請求項14記載の方法において、前記酵素は、BE7(配列ID番号2)を有するものである。
- 請求項14記載の方法において、前記酵素は、BF4(配列ID番号3)を有するものである。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72062805P | 2005-09-26 | 2005-09-26 | |
US60/720,628 | 2005-09-26 | ||
PCT/US2006/037554 WO2007038548A2 (en) | 2005-09-26 | 2006-09-26 | Compositions and methods of using chondroitinase abci mutants |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009509532A true JP2009509532A (ja) | 2009-03-12 |
JP2009509532A5 JP2009509532A5 (ja) | 2009-09-17 |
JP5189985B2 JP5189985B2 (ja) | 2013-04-24 |
Family
ID=37900402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008533536A Expired - Fee Related JP5189985B2 (ja) | 2005-09-26 | 2006-09-26 | コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 |
Country Status (7)
Country | Link |
---|---|
US (7) | US7485295B2 (ja) |
EP (1) | EP1928490B8 (ja) |
JP (1) | JP5189985B2 (ja) |
AU (1) | AU2006294755B2 (ja) |
CA (1) | CA2623635C (ja) |
ES (1) | ES2393748T3 (ja) |
WO (1) | WO2007038548A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1575548B1 (en) | 2002-05-04 | 2011-03-09 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
ATE508197T1 (de) * | 2002-08-15 | 2011-05-15 | Acorda Therapeutics Inc | Chimärisches protein |
AU2004241088B2 (en) * | 2003-05-16 | 2010-08-05 | Acorda Therapeutics, Inc. | Compositions and methods for the treatment of CNS injuries |
US7959914B2 (en) * | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
ES2616749T3 (es) | 2003-05-16 | 2017-06-14 | Acorda Therapeutics, Inc. | Mutantes degradantes del proteoglucano para el tratamiento del SNC |
WO2005112986A2 (en) * | 2004-05-18 | 2005-12-01 | Acorda Therapeutics, Inc. | Purifying chondroitinase and stable formulations thereof |
JP5189985B2 (ja) | 2005-09-26 | 2013-04-24 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 |
CA2652675C (en) | 2006-05-19 | 2015-11-24 | Aichi Prefecture | Chondroitin sulfate degradation to ameliorate brain damage induced by hypoxia |
JP5391069B2 (ja) | 2006-10-10 | 2014-01-15 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を使用する組成物及び方法 |
CN112126606B (zh) * | 2020-10-18 | 2022-09-30 | 山东大学 | 一株发光杆菌qa16及其培养方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005087920A2 (en) * | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270194A (en) | 1989-08-31 | 1993-12-14 | Instrumentation Laboratory Spa | Stabilized glucose oxidase from Aspergillus Niger |
CA2071898A1 (en) | 1989-10-27 | 1991-04-28 | Diane M. Snow | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
US5674980A (en) | 1989-12-21 | 1997-10-07 | Biogen Inc | Fusion protein comprising tat-derived transport moiety |
US5804604A (en) | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
US5679650A (en) | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
US5262522A (en) | 1991-11-22 | 1993-11-16 | Immunex Corporation | Receptor for oncostatin M and leukemia inhibitory factor |
US6087323A (en) | 1992-04-03 | 2000-07-11 | Cambridge Neuroscience, Inc. | Use of neuregulins as modulators of cellular communication |
JP3980657B2 (ja) | 1992-06-26 | 2007-09-26 | 生化学工業株式会社 | コンドロイチナーゼabc、その製造法及び医薬組成物 |
US5496718A (en) | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
US7008783B1 (en) | 1992-09-22 | 2006-03-07 | Maruha Corporation | Gene encoding chondroitinase ABC and uses therefor |
WO1994025567A1 (en) | 1993-04-23 | 1994-11-10 | American Cyanamid Company | CLONING AND EXPRESSION OF THE CHONDROITINASE I AND II GENES FROM $i(P. VULGARIS) |
US5578480A (en) * | 1993-04-23 | 1996-11-26 | American Cyanamid Company | Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris |
US6248562B1 (en) | 1993-11-01 | 2001-06-19 | Research Foundation State University Of New York | Chimeric proteins comprising borrelia polypeptides and uses therefor |
AU1176595A (en) | 1993-11-12 | 1995-05-29 | International Technology Management Associates, Ltd. | Methods of repairing connective tissues |
US5498536A (en) * | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
EP0704532B1 (en) | 1994-06-10 | 2002-09-11 | United States Surgical Corporation | Recombinant chimeric proteins and methods of use thereof |
US6093563A (en) | 1994-07-08 | 2000-07-25 | Ibex Technologies R And D, Inc. | Chondroitin lyase enzymes |
US5997863A (en) * | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
US6326166B1 (en) | 1995-12-29 | 2001-12-04 | Massachusetts Institute Of Technology | Chimeric DNA-binding proteins |
AU4658596A (en) | 1995-02-03 | 1996-08-21 | G.D. Searle & Co. | Novel c-mpl ligands |
US5792743A (en) * | 1995-04-19 | 1998-08-11 | Acorda Therapeutics | Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule |
US6313265B1 (en) * | 1995-07-24 | 2001-11-06 | The Scripps Research Institute | Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use |
US5869301A (en) | 1995-11-02 | 1999-02-09 | Lockhead Martin Energy Research Corporation | Method for the production of dicarboxylic acids |
JP3702450B2 (ja) | 1996-12-18 | 2005-10-05 | ニプロ株式会社 | 乳酸脱水素酵素測定用試薬 |
AU6897198A (en) | 1997-04-11 | 1998-11-11 | Beth Israel Deaconess Medical Center | Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions |
JP4172842B2 (ja) | 1997-05-02 | 2008-10-29 | 生化学工業株式会社 | コンドロイチナーゼ組成物 |
EP0875253B1 (en) * | 1997-05-02 | 2005-04-06 | Seikagaku Corporation | Chondroitinase compositions |
AU735216B2 (en) | 1997-08-22 | 2001-07-05 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
US6153187A (en) | 1997-09-02 | 2000-11-28 | Insight Strategy & Marketing Ltd. | Use of glycosaminoglycans degrading enzymes for management of airway associated diseases |
US20010006630A1 (en) | 1997-09-02 | 2001-07-05 | Oron Yacoby-Zeevi | Introducing a biological material into a patient |
PT1887014E (pt) | 1997-10-17 | 2010-07-05 | Genentech Inc | Homëlogos de toll humana |
AU2662799A (en) | 1998-02-13 | 1999-08-30 | Medinox, Inc. | Modified pharmacologically active agents and improved therapeutic methods employing same |
AU3006899A (en) | 1998-03-13 | 1999-09-27 | Biomarin Pharmaceutical Inc. | Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment |
CA2322748A1 (en) | 1998-03-13 | 1999-09-16 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
US6171575B1 (en) | 1998-04-06 | 2001-01-09 | Shinichi Okuyama | Method of radioisotopic assessment of the integrity and function of the nose-brain barrier |
EP1109919A2 (en) | 1998-08-27 | 2001-06-27 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
AU772479B2 (en) | 1998-10-06 | 2004-04-29 | Stryker Corporation | Repair of larynx, trachea, and other fibrocartilaginous tissues |
CA2364690A1 (en) | 1999-02-28 | 2000-10-19 | Washington University | Novel transduction molecules and methods for using same |
CA2365040A1 (en) | 1999-04-02 | 2000-10-12 | Eli Lilly And Company | Hob-bp2h compositions, methods and uses thereof |
SE9901428D0 (sv) | 1999-04-21 | 1999-04-21 | Karolinska Innovations Ab | Amphibodies |
ATE293164T1 (de) | 1999-06-08 | 2005-04-15 | Regeneron Pharma | Modifizierte chimärische polypeptide mit verbesserten pharmakokynetischen eigenschaften |
CA2393186A1 (en) | 1999-12-02 | 2001-06-07 | Ibex Technologies, Inc. | Attenuation of fibroblast proliferation |
DE60142023D1 (de) | 2000-01-12 | 2010-06-17 | Univ Yale | Nogo rezeptor-vermittelte blockade des axonalen wachstums |
WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
WO2002008285A2 (en) | 2000-06-22 | 2002-01-31 | Amgen, Inc. | Il-17 molecules and uses thereof |
JP2004532809A (ja) | 2000-11-02 | 2004-10-28 | リサーチ ファウンデーション オブ シティ ユニバーシティ オブ ニューヨーク | ホスホジエステラーゼ4型を阻害することによって、神経系の再生および修復を刺激するための方法 |
US20050069537A1 (en) | 2000-12-12 | 2005-03-31 | Vladimir Berezin | Survical promoting ncam binding and ncam ligand binding compounds |
US20020142299A1 (en) | 2001-01-09 | 2002-10-03 | Davidson Beverly L. | PTD-modified proteins |
GB0103174D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Plc | Novel method of treatment |
US7045290B2 (en) | 2001-02-15 | 2006-05-16 | The University Of Chicago | Yeast screens for treatment of human disease |
CA2367636C (en) | 2001-04-12 | 2010-05-04 | Lisa Mckerracher | Fusion proteins |
WO2003000901A2 (en) | 2001-06-26 | 2003-01-03 | Decode Genetics Ehf. | Nucleic acids encoding protein kinases |
MXPA04001334A (es) | 2001-08-13 | 2004-05-05 | Univ Florida | Materiales y metodos para promover la reparacion de tejido nervioso. |
US20030049258A1 (en) | 2001-09-11 | 2003-03-13 | Martin Ungerer | Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
WO2003031578A2 (en) | 2001-10-09 | 2003-04-17 | Immunex Corporation | Mammalian c-type lectins |
US20030127812A1 (en) | 2002-01-04 | 2003-07-10 | Charles Mehrmann | Bi-directional sliding board |
GB0205022D0 (en) | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
EP1575548B1 (en) | 2002-05-04 | 2011-03-09 | Acorda Therapeutics, Inc. | Compositions and methods for promoting neuronal outgrowth |
US7807618B2 (en) | 2002-05-20 | 2010-10-05 | The Board Of Regents Of The University Of Texas System | Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues |
DE60334220D1 (de) | 2002-06-03 | 2010-10-28 | Massachusetts Inst Technology | Rationell konstruierte, von chondroitinase b abgeleitete lyasen |
US7163545B2 (en) | 2002-07-29 | 2007-01-16 | Mayo Foundation For Medical Education And Research | Spinal cord surgical implant |
US7074581B2 (en) | 2002-08-09 | 2006-07-11 | Sysmex Corporation | Reagent for assaying lipid |
JP4527950B2 (ja) | 2002-08-09 | 2010-08-18 | シスメックス株式会社 | 脂質測定試薬 |
CA2495121A1 (en) | 2002-08-10 | 2004-02-19 | Yale University | Nogo receptor antagonists |
ATE508197T1 (de) | 2002-08-15 | 2011-05-15 | Acorda Therapeutics Inc | Chimärisches protein |
JP2004113166A (ja) | 2002-09-27 | 2004-04-15 | Mitsui Chemicals Inc | ハロペルオキシダ−ゼ活性の安定化方法 |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
EP1646353A4 (en) | 2003-05-16 | 2008-06-04 | Acorda Therapeutics Inc | FUSION PROTEINS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM |
AU2004241088B2 (en) | 2003-05-16 | 2010-08-05 | Acorda Therapeutics, Inc. | Compositions and methods for the treatment of CNS injuries |
ES2616749T3 (es) | 2003-05-16 | 2017-06-14 | Acorda Therapeutics, Inc. | Mutantes degradantes del proteoglucano para el tratamiento del SNC |
WO2005112986A2 (en) | 2004-05-18 | 2005-12-01 | Acorda Therapeutics, Inc. | Purifying chondroitinase and stable formulations thereof |
JP5189985B2 (ja) * | 2005-09-26 | 2013-04-24 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を用いた組成物およびその使用方法 |
JP5092329B2 (ja) | 2006-09-26 | 2012-12-05 | 栗田工業株式会社 | 短波長紫外線放電灯及び紫外線照射処理装置 |
JP5391069B2 (ja) | 2006-10-10 | 2014-01-15 | アコーダ セラピューティクス、インク. | コンドロイチナーゼabci変異体を使用する組成物及び方法 |
-
2006
- 2006-09-26 JP JP2008533536A patent/JP5189985B2/ja not_active Expired - Fee Related
- 2006-09-26 ES ES06815505T patent/ES2393748T3/es active Active
- 2006-09-26 WO PCT/US2006/037554 patent/WO2007038548A2/en active Application Filing
- 2006-09-26 CA CA2623635A patent/CA2623635C/en not_active Expired - Fee Related
- 2006-09-26 US US11/527,318 patent/US7485295B2/en active Active
- 2006-09-26 EP EP06815505A patent/EP1928490B8/en active Active
- 2006-09-26 AU AU2006294755A patent/AU2006294755B2/en not_active Ceased
-
2008
- 2008-12-18 US US12/338,207 patent/US7731956B2/en not_active Expired - Fee Related
-
2010
- 2010-06-04 US US12/757,006 patent/US8236302B2/en active Active
-
2012
- 2012-07-06 US US13/543,749 patent/US8852583B2/en not_active Expired - Fee Related
-
2014
- 2014-09-08 US US14/480,486 patent/US9402886B2/en active Active
-
2016
- 2016-07-21 US US15/216,039 patent/US9834764B2/en active Active
-
2017
- 2017-10-20 US US15/789,384 patent/US10323240B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005087920A2 (en) * | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
Non-Patent Citations (3)
Title |
---|
JPN6011062099; Biochem J., 2005年9月1日, 第390巻, 395-405ページ * |
JPN6011062101; J Mol Biol., 2003年, 第328巻, 623-634ページ * |
JPN6011062103; Nature, 2002年, 第416巻, 636-640ページ * |
Also Published As
Publication number | Publication date |
---|---|
US9402886B2 (en) | 2016-08-02 |
EP1928490A4 (en) | 2010-03-31 |
EP1928490B1 (en) | 2012-08-29 |
JP5189985B2 (ja) | 2013-04-24 |
US9834764B2 (en) | 2017-12-05 |
US20150190483A1 (en) | 2015-07-09 |
US8236302B2 (en) | 2012-08-07 |
US20070104703A1 (en) | 2007-05-10 |
AU2006294755B2 (en) | 2012-04-19 |
EP1928490B8 (en) | 2012-10-03 |
US7731956B2 (en) | 2010-06-08 |
WO2007038548A3 (en) | 2009-05-07 |
US20100239557A1 (en) | 2010-09-23 |
ES2393748T3 (es) | 2012-12-27 |
US20120308547A1 (en) | 2012-12-06 |
CA2623635C (en) | 2013-04-02 |
US7485295B2 (en) | 2009-02-03 |
US10323240B2 (en) | 2019-06-18 |
EP1928490A2 (en) | 2008-06-11 |
WO2007038548A2 (en) | 2007-04-05 |
US8852583B2 (en) | 2014-10-07 |
AU2006294755A1 (en) | 2007-04-05 |
CA2623635A1 (en) | 2007-04-05 |
US20180066245A1 (en) | 2018-03-08 |
US20090104176A1 (en) | 2009-04-23 |
US20170009222A1 (en) | 2017-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10323240B2 (en) | Compositions and methods of using chondroitinase ABCI mutants | |
US9987340B2 (en) | Compositions and methods of using chondroitinase ABCI mutants | |
AU2016206267B2 (en) | Compositions and methods of using chondroitinase abci mutants | |
AU2014200000B2 (en) | Compositions and methods of using chondroitinase abci mutants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090730 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090730 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120229 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120307 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120529 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120626 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120926 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20121003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121026 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20121227 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20130110 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130125 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160201 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5189985 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |